<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Funderburg NT</submitter><funding>NCATS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>4599-608</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3512236</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>120(23)</volume><pubmed_abstract>The mechanisms responsible for increased cardiovascular risk associated with HIV-1 infection are incompletely defined. Using flow cytometry, in the present study, we examined activation phenotypes of monocyte subpopulations in patients with HIV-1 infection or acute coronary syndrome to find common cellular profiles. Nonclassic (CD14(+)CD16(++)) and intermediate (CD14(++)CD16(+)) monocytes are proportionally increased and express high levels of tissue factor and CD62P in HIV-1 infection. These proportions are related to viremia, T-cell activation, and plasma levels of IL-6. In vitro exposure of whole blood samples from uninfected control donors to lipopolysaccharide increased surface tissue factor expression on all monocyte subsets, but exposure to HIV-1 resulted in activation only of nonclassic monocytes. Remarkably, the profile of monocyte activation in uncontrolled HIV-1 disease mirrors that of acute coronary syndrome in uninfected persons. Therefore, drivers of immune activation and inflammation in HIV-1 disease may alter monocyte subpopulations and activation phenotype, contributing to a pro-atherothrombotic state that may drive cardiovascular risk in HIV-1 infection.</pubmed_abstract><journal>Blood</journal><pubmed_title>Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.</pubmed_title><pmcid>PMC3512236</pmcid><funding_grant_id>R24 AI067039</funding_grant_id><funding_grant_id>R37 HL057506</funding_grant_id><funding_grant_id>AI-67039</funding_grant_id><funding_grant_id>1K99HL108743-01A1</funding_grant_id><funding_grant_id>U01 AI068636</funding_grant_id><funding_grant_id>AI-68636</funding_grant_id><funding_grant_id>KL2 TR000440</funding_grant_id><funding_grant_id>UM1 AI068636</funding_grant_id><funding_grant_id>P30 AI036219</funding_grant_id><funding_grant_id>AI-07164</funding_grant_id><funding_grant_id>T32 AI089474</funding_grant_id><funding_grant_id>K99 HL108743</funding_grant_id><pubmed_authors>Zidar DA</pubmed_authors><pubmed_authors>Simon DI</pubmed_authors><pubmed_authors>Funderburg NT</pubmed_authors><pubmed_authors>Lioi A</pubmed_authors><pubmed_authors>Mudd J</pubmed_authors><pubmed_authors>Musselwhite LW</pubmed_authors><pubmed_authors>Sieg SF</pubmed_authors><pubmed_authors>Shive C</pubmed_authors><pubmed_authors>Costa MA</pubmed_authors><pubmed_authors>Lederman MM</pubmed_authors><pubmed_authors>Rodriguez B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.</name><description>The mechanisms responsible for increased cardiovascular risk associated with HIV-1 infection are incompletely defined. Using flow cytometry, in the present study, we examined activation phenotypes of monocyte subpopulations in patients with HIV-1 infection or acute coronary syndrome to find common cellular profiles. Nonclassic (CD14(+)CD16(++)) and intermediate (CD14(++)CD16(+)) monocytes are proportionally increased and express high levels of tissue factor and CD62P in HIV-1 infection. These proportions are related to viremia, T-cell activation, and plasma levels of IL-6. In vitro exposure of whole blood samples from uninfected control donors to lipopolysaccharide increased surface tissue factor expression on all monocyte subsets, but exposure to HIV-1 resulted in activation only of nonclassic monocytes. Remarkably, the profile of monocyte activation in uncontrolled HIV-1 disease mirrors that of acute coronary syndrome in uninfected persons. Therefore, drivers of immune activation and inflammation in HIV-1 disease may alter monocyte subpopulations and activation phenotype, contributing to a pro-atherothrombotic state that may drive cardiovascular risk in HIV-1 infection.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Nov</publication><modification>2024-12-03T18:49:02.162Z</modification><creation>2019-03-27T01:01:20Z</creation></dates><accession>S-EPMC3512236</accession><cross_references><pubmed>23065151</pubmed><doi>10.1182/blood-2012-05-433946</doi></cross_references></HashMap>